Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Lithuanian biotech growing fast

31.03.2008
The Lithuanian biotech sector's sales have grown by about 22 % each year for the last 5 years according to the Lithuanian Biotechnology Association. Two modern biotechnology companies: Fermentas Ltd. and Sicor Biotech Ltd. operate in Lithuania for more than 10 years. The sales of both companies in 2007 exceeded 28 mln. Euros.

Fermentas Ltd. is a R&D and manufacturing company, which develop and produce products for genetic engineering, molecular biology, genomic research and other biotechnological investigations (over 400 items). More than 99 % of the products are exported. Expansion of efforts to the field of molecular diagnostics is taking place at the present time. Big scale production of kits for molecular diagnostics is planned.

The enterprise of biotechnological pharmacy Sicor Biotech Ltd. in Lithuania is producing recombinant proteins for medical use (interferon alpha-2b, human growth hormone, granulocyte colonies stimulating factor, erythropoietin). It is the only factory of such a profile in Eastern and Central Europe. Sicor Biotech Ltd. is a member of TEVA group (TEVA Pharmaceutical Industries Ltd., Israel). It has strong and very well equipped research centre, developing technologies for production of recombinant proteins.

The success of Lithuanian Biotech is underscored by the fact that the Institute of Biotechnology in Vilnius has attracted back to Lithuania seventeen (17) scientists who have spent over 3 years abroad. They have now returned to carry out their research in Lithuania bringing with them experience, knowledge and funds.

... more about:
»Bioregion »Biotech »Biotechnology »Lithuanian

The Lithuanian government has increased funding of biotech research in the last five years and established new programs such as the Industrial Biotechnology Program. Very appropriate, this year's ScanBalt Forum takes place in Vilnius 24-26 September, organized by the Institute of Biotechnology and the Lithuanian Association of Biotechnology and in parallel with the annual ScanBalt Biomaterial Days. Read more at http://www.scanbalt.org/forum2008

The responsible organizer of ScanBalt Forum 2008, dr. Daumantas Matulis, the head of Laboratory of Biothermodynamics and Drug Design, Institute of Biotechnology, says: "The growing importance of life sciences and biotechnology in Lithuania is being recognized with ScanBalt Forum 2008 to take place in Vilnius. This is a chance to promote Lithuania as an attractive place to work, live and invest. We intend to further strengthen our position as a strong player within life sciences and biotechnology in the Baltic Sea Region - also called ScanBalt BioRegion".

For further information contact Daumantas Matulis at: +370 650 06560 or matulis@ibt.lt

About Institute of Biotechnology:
IBT is State Research Institute and the leading biotechnology center in Lithuania active in multidisciplinary studies of restriction - modification enzymes, and the research and development of recombinant biomedical proteins. IBT has 7 laboratories specializing in Protein-DNA Interactions, Biological DNA Modification, Prokaryote Gene Engineering, Eukaryote Gene Engineering, Immunology, Biothermodynamics and Drug Design and Bioinformatics.
IBT aims to strengthen the cooperation in the field of Biochemistry, Biotechnology and Biomedicine, enhance networking of academic and industrial sectors and the development of international collaboration and knowledge exchange by maintaining the stimulating competitiveness both in research and commercial applications. IBT boost the initiation of the dialogue with policy makers, best scientific, business leaders on national and international scale.

Read more at http://www.ibt.lt

About ScanBalt BioRegion and ScanBalt:
ScanBalt BioRegion is composed of Life Science and biotechnology actors in the Nordic, Baltic countries, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion have 11 countries and 85 million people, more than 60 universities and 2173 life science/biotech companies including 671 research based biotech SME´s. ScanBalt facilitates and co-ordinates regional and national efforts in ScanBalt BioRegion. It enhances visibility and attracts human, industrial and financial resources to the region and to the members. ScanBalt encompasses regional and national life science triple helix networks between companies, universities, hospitals, tech transfer organisations and public authorities.

Peter Frank | idw
Further information:
http://www.scanbalt.org
http://www.scanbalt.org/forum2008

Further reports about: Bioregion Biotech Biotechnology Lithuanian

More articles from Life Sciences:

nachricht Rainbow colors reveal cell history: Uncovering β-cell heterogeneity
22.09.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden

nachricht The pyrenoid is a carbon-fixing liquid droplet
22.09.2017 | Max-Planck-Institut für Biochemie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>